Skip to main content

Clinical efficacy and acceptability of remote fetal heart rate self-monitoring in Southern China

Abstract

Background

Compared to traditional fetal heart rate monitoring (FHR) for the outpatients in clinic, remote FHR monitoring shows real-time assessment of fetal wellbeing at home. The clinical function of remote FHR monitoring in pregnant wome in outpatient is still unclear.

Objective

To explore the feasibility of remote FHR self-monitoring in singleton pregnant women from southern China.

Study design

This prospective cohort study was conducted at one tertiary center in southern China. Pregnant women used a mobile cardiotocogram device to measure the FHR at least once a week until delivery in the remote group. For the control group, pregnant women underwent traditional FHR monitoring once a week in the outpatient clinic. The rate of cesarean section, risk of postpartum hemorrhage and adverse neonatal outcomes were compared between the two groups. All the pregnant women completed a questionnaire survey to evaluate their acquisition of remote FHR self-monitoring.

Results

Approximately 500 women were recruited in the remote FHR self-monitoring group (remote group), and 567 women were recruited in the traditional FHR monitoring group (control group). The women in the remote FHR monitoring group were more likely to be nulliparous (P < 0.001), more likely to have a higher education level (P < 0.001) and more likely to be at high risk (P = 0.003). There was no significant difference in the risk of cesarean section (P = 0.068) or postpartum hemorrhage (P = 0.836) between the two groups. No difference in fetal complications was observed across groups, with the exception of the incidence of NICU stays, which was higher in the remote group (12.0% vs. 8.3%, P = 0.044). The questionnaire survey showed that the interval time (P = 0.001) and cost (P = 0.010) of fetal heart rate monitoring were lower in the remote group. Regarding age, prepregnancy BMI, risk factors, education level, maternal risk and household income, senior high school (OR 2.86, 95% CI 1.67–4.90, P < 0.001), undergraduate (OR 2.96, 95% CI 1.73–5.06, P < 0.001), advanced maternal age (OR 1.42, 95% CI 1.07–1.89, P = 0.015) and high-risk pregnancy (OR 1.61, 95% CI 1.11–2.35, P = 0.013) were independent factors for pregnant women to choose remote fetal monitoring. Multiparty (OR 0.33, 95% CI 0.21–0.51, P < 0.001), full-time motherhood (OR 0.47, 95% CI 0.33–0.678, P < 0.001) and high household income (OR 0.67, 95% CI 0.50–0.88, P = 0.004) were negatively correlated with the choice of remote FHR self-monitoring.

Conclusion

Remote FHR self-monitoring technology has a lower cost and shows potential clinical efficacy for the outpatient setting in southern China. This approach does not increase the risk of cesarean section or adverse neonatal outcomes. It is acceptable among nulliparous pregnant women with a high education level, high household income or high risk. Further research is needed to assess the impact of this technology on obstetric outcomes in different health settings.

Peer Review reports

Introduction

Globally, more than 3.8 million perinatal deaths, including 2 million stillbirths, occur each year [1]. More than 98% of stillbirths occur in developing countries, which is 10 times greater than the rate in developed countries [1]. In southern China, the perinatal mortality was 13.5 per 1000 births in 2019 owing to the lack of continuous electronic fetal heart rate (FHR) monitoring [2]. FHR monitoring, which is the primary method for the early detection of abnormal fetal wellbeing, provides an opportunity for effective intervention to prevent neonatal morbidity and mortality [3]. In general, the traditional devices for FHR monitoring require pregnant women to go to the hospital, thus limiting their use to the clinic. This traditional FHR monitoring model also limits routine observations to pregnant women at one period and is restrictive to an examination couch. It is difficult for women who live far from the hospital to attend 1 or 2 times a week, as is recommended for women with a high-risk pregnancy [4]. Although the distances to the hospital are short in general, the travel time to reach the hospital is often unpredictable. In general, the time interval between the arrival of pregnant women at the care unit and the decision to perform surgery is more than 3 h, owing to the unpredictable travel time when pregnancies felt terrible. The above barrier to health care has been highlighted in the context of the COVID-19 pandemic [5].

Telemedicine, which is the exchange of information among physically distant clinical sites via telecommunications, enables health care across distances, particularly in rural areas, thereby avoiding unnecessary visits to tertiary centers [6]. Wireless remote FHR monitoring systems transmit fetal heart rate data to a central sever either through the web or Bluetooth, thus allowing real-time assessment of fetal wellbeing. Remote FHR monitoring have become a mainstream tendency. Pilot studies have demonstrated that this remote FHR monitoring system is feasible and acceptable among both pregnant women and obstetric outpatient clinics in developed countries [7]. To date, a wireless, remote fetal monitoring system composed of a wireless belt and acoustic sensor has been promoted as at-home fetal monitoring for high-risk pregnant women, especially in pregnant women who cannot move up to obstetric care for routine visits [8].

Remote fetal monitoring has become crucial in the management of high-risk pregnancies to improve the assessment of fetal well-being [9, 10]. The remote fetal monitoring system could reduce prenatal visits. A previous study demonstrated that a reduction in perinatal visits was recommended for low-risk pregnancies and did not increase adverse maternal or fetal outcomes [11]. Yvonne [12] reported that wireless remote fetal monitoring yields an equally satisfying experience as traditional perinatal care without an increase in perinatal complications. Recently, wireless remote fetal monitoring was recommended for pregnancies during the present COVID-19 pandemic. Rossignol [13] identified that electronic fetal monitoring increased the risk of cesarean section. However, compared to the traditional FHR monitoring, it’s controversial that increased use of remote fetal monitoring system, variance in interpretation and intervention led to increased rate of cesarean section.

Therefore, it is important to introduce a remote fetal monitoring method to empower pregnant women to perform fetal surveillance at home, thereby improving maternal and neonatal outcomes without increasing rate of cesarean section. Besides, the cost of antenatal care varies in different regions of China. Feng [14] reported that the frequency and contents of antenatal care was associated with regional differences, as well as the socio-economic status of the pregnant women in China. The purpose of the present study was to explore impact on delivery mode and cost effectiveness of the remote fetal monitoring system for antenatal care in rural areas of Guangdong Province.

Material and methods

A prospective study evaluated the use of wireless remote FHR self-monitoring on obstetric outcomes compared to traditional FHR monitoring in a single tertiary center in southern China. The study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of Sun Yat-sen University (No. 21-413) and Zhongshan Public welfare science and technology research Founadtion (No.2019B1012).

Singleton pregnancies without serious complications were eligible to participate in the study if they were 20 years of age or older, able to consent, and at 34 weeks of gestation or later. The exclusion criteria included multiple gestations, uncontrolled hypertension, preeclampsia, uncontrolled gestational diabetes mellitus and fetal abnormalities. Enrollment occurred from January 2021 through December 2021 at a tertiary referral maternity unit. Women were approached by trained research assistants in the antenatal setting. All women provided written informed consent to participate in this study. The demographic characteristics and medical history of all participants were reviewed by a doctor. High-risk was defined as the women complicated with advanced maternal age (≥ 35 years old), history of abnormal pregnancy, gestational hypertension, gestational diabetes mellitus, intrahepatic cholestasis of pregnancy, immune diseases such as systemic lupus erythematosus, rheumatoid arthritis, connective tissue disease, nephritis, heart disease, fetal growth restriction, placenta previa, beach position. If the participant underwent traditional FHR monitoring, FHR monitoring was applied for them once a week. The participant who took remote FHR monitoring, a minimal FHR monitoring frequency of one was required everyday. Once the abnormal results, including low variability, bradycardia, tachycardia, decelerations, and sinusoidal patterns, were identified, the patients were informed to visit a hospital.

The primary outcome was the rate of cesarean section. Secondary outcomes for pregnancies included gestational age at birth, postpartum hemorrhage (≥ 500 ml), and adverse neonatal outcomes. Adverse neonatal outcomes included fetal distress, neonatal asphyxia (Apgar score < 7 at 1 min), preterm birth (gestational age at delivery < 37 weeks), meconium-stained amniotic fluid, low birth weight (LBW < 2500 g), macrosomia (neonatal birth weight ≥ 4000 g), admission to the neonatal intensive care unit (NIUC) and neonatal death. In addition, a questionnaire survey about the satisfaction and cost of fetal monitoring, including the awareness of the importance of antenatal fetal heart rate monitoring, the interval time of taking non-stress test, the travel time and the travelling expense to hospital from home, the frequency of remote FHR monitrong, and the knowledge of antenatal fetal heart rate monitoring, was administered to patients to detect differences across groups. The study aimed to identify factors that affected the use of remote FHR self-monitoring.

Statistical analysis

Categorical variables were summarized using frequency, presenting counts and relative percentages, and were compared by using Fisher’s exact test. Logistic analysis was used for the impact on willing of remote FHR monitoring, regarding education level, gradity, parity, career, high-risk status, pre-pregnancy BMI, rate of abortion, assisted reproduction. A 95% confidence interval (CI) was calculated for the willing rate. Statistical analysis was performed using SPSS software version 23.0 (Copyright, SPSS, USA).

Results

From January 2021 through December 2021, a total of 1344 pregnant women were screened for eligibility. There were 254 cases admitted to outher facility, 12 cases suffered from uncontrolled hypertension at delivery, and 1 case complicated with serious preelampsia. A total 1067 pregnant women were enrolled in our study. None of them withdrew their consent or were lost to follow-up during the study period. There were 500 women in the remote FHR self-monitoring group (remote group) and 567 women in the traditional FHR monitoring group (control group). The flow of participants and completeness of data were similar across groups (Fig. 1).

Fig. 1
figure 1

Enrollment and the flow of participants

Table 1 enumerates the clinical characteristics and social background between the two groups. There was a higher proportion of nulliparous women in the remote FHR group (58.0% vs. 44.6%, P < 0.001). Approximately 68.8% of the remote group had high-risk pregnancies, while 60.0% of the control group had high-risk pregnancies (P = 0.003). Compared to women in the control group, women in the remote group had a higher education level (P < 0.001). The proportion of full-time mothers was lower in the remote group (P < 0.001). The demographic characteristics, including age, prepregnancy BMI, gravidity, abortion, assisted reproduction and household income, were similar for these groups.

Table 1 The characteristics of pregnant women between remote group and control group

As shown in Table 2, the maternal and neonatal outcomes were summarized between the two groups. In the remote group, 37.6% of women underwent cesarean section, whereas 32.3% of women in the control group underwent cesarean section (P = 0.068). There was no significant difference in the incidence of postpartum hemorrhage (1.60% vs. 1.76%, P = 0.836). The incidence of admittion of NICU was higher in remote group compared to the control group (12.0% vs. 8.3%, P = 0.044). There was no significant difference in the risk of adverse neonatal outcomes, including fetal distress (4.60% vs. 3.35%, P = 0.295), neonatal asphyxia (4.005 vs. 1.235, P = 0.483), preterm birth (6.405 vs. 7.58%, P = 0.450), meconium-stained amniotic fluid (10.80% vs. 10.93%, P = 0.944), low birth weight (4.40% vs. 5.47%, P = 0.423), macrosomia (3.60 vs. 2.47%, P = 0.280) and neonatal death (0.20% vs. 0.71%, P = 0.379).

Table 2 The obstetric outcomes between remote group and control group

Table 3 shows the details of the questionnaire survey conducted after delivery. The interval time (P = 0.001) and cost (P = 0.010) of fetal heart rate monitoring in the clinic were lower in the remote group. Compared to women in the control group, pregnancies in the remote group have a more comprehensive knowledge of common sense regarding fetal heart rate monitoring, such as appropriate interval time, the optimal time and the frequency of fetal surveillance. There was no significant difference in awareness of the necessity of weekly fetal heart rate monitoring across groups.

Table 3 The result of questionnaire survey between remote group and control group

The influencing factors of choosing remote fetal heart monitoring were evaluated by logistic regression analysis (Table 4). Women with higher education levels, such as senior high school (OR 2.86, 95% CI 1.67–4.90, P < 0.001) and undergraduate (OR 2.96, 95% CI 1.73–5.06, P < 0.001), chose remote fetal heart rate monitoring. Moreover, advanced maternal age (OR 1.42, 95% CI 1.07–1.89, P = 0.015) and high-risk pregnancy (OR 1.61, 95% CI 1.11–2.35, P = 0.013) were independent factors for pregnant women to choose remote fetal monitoring. Multiparity (OR 0.33, 95% CI 0.21–0.51, P < 0.001), full-time mothers (OR 0.47, 95% CI 0.33–0.678, P < 0.001) and high household income (OR 0.67, 95% CI 0.50–0.88, P = 0.004) were negatively correlated with the choice of remote fetal heart rate monitoring. The prepregnancy BMI, abortion and assisted reproduction were not correlated with the choice of remote fetal heart rate monitoring.

Table 4 The Logistic analysis of impact on willing of remote FHR monitoring

Discussion

Our study revealed that after 34 gestational weeks, pregnant women were able to use a remote wireless CTG device, which is accurate and safe for self-monitoring of fetal heart rate (FHR) at home. The clinical efficacy of remote FHR self-monitoring is equivalent to that in the clinic without increasing the risk of cesarean section. Besides, remote FHR self-monitoring did not increase the risk of postpartum hemorrhage or adverse neonatal outcomes. In addition, the questionnaire survey that administered after delivery showed that most pregnant women who chose remote CTG devices spent less time and money on FHR monitoring and had a more comprehensive knowledge. Education level, household income, and party and occupational status were considered impact factors for the use of remote FHR self-monitoring in pregnant women.

Based on our findings, remote FHR self-monitoring could facilitate the improvement of antenatal care modes. During the COVID-19 pandemic, remote surveillance of fetuses should be robust and safe. The usability and accuracy of remote FHR self-monitoring at home, as well as its ability to improve maternal engagement and wellbeing, make it feasible to be used as a supplement to traditional antepartum care in the clinic. In accordance with the present study, Kerner and coworkers [15] investigated the readability of FHR tracings of 36 high-risk pregnancies with FHR self-monitoring and showed the feasibility of remote FHR self-monitoring at home. We also revealed that remote FHR monitoring did not increase the risk of cesarean section and postpartum hemorrhage in singleton gestations. Similarly, Tamaru [16] and coworkers reported the feasibility of using remote FHR monitoring. They analyzed 1278 records of remote FHR monitoring from 101 pregnant women at low risk and determined that the obstetric outcomes were not affected by the abnormal records of remote FHR monitoring, according to the JSOG system.

In addition, Monincx [17] and colleagues conducted a randomized controlled trial to assess fetal surveillance with remote FHR monitoring. A total of 76 pregnant women at high risk were enrolled in remote antenatal care, and 74 pregnancies were enrolled in hospital care. There was no difference in perinatal morbidity between these two groups. Our study also found that the risk of perinatal morbidity did not increase in pregnant women at high risk. Furthermore, the utility of remote FHR self-monitoring did not mitigate or increase adverse neonatal outcomes. Rather than proving perinatal benefits in light of improved fetal morbidity and mortality, our study revealed the feasibility of remote FHR self-monitoring. The usability results of the present study were consistent with those of a previously published study. A potential advantage of the use of remote FHR self-monitoring is that it is less likely to cause adverse maternal and neonatal outcomes. Remote FHR self-monitoring was found to support outpatient concerns, such as decreased fetal movement [8]. Therefore, the clinical benefits of remote FHR self-monitoring suggest that it should be expanded, and that additional rigorous research should be performed.

Not only the feasibility of remote FHR self-monitoring for pregnancy but also satisfaction and cost should be considered important factors in perinatal telemedicine. A retrospective cohort [18] of 77 pregnant women using remote FHR self-monitoring at home revealed that the usage and satisfaction were lower than those for traditional FHR monitoring in the clinic via a questionnaire survey. In contrast, Kerner [15] and colleagues administered a questionnaire survey regarding the anxiety status of pregnancies to determine the satisfaction of remote FHR monitoring at home and found that an absence of anxiety occurred in those pregnancies. Recently, facilities and expectations for the use of remote FHR self-monitoring were found in the majority of remote groups. Our survey also showed that the time and cost of FHR monitoring were lower in the remote group. In line with our findings, Fanelli [19] and coworkers revealed that FHR self-monitoring at home reduced the cost of fetal monitoring. Considering the equivalent impact of fetal surveillance and low cost, remote FHR self-monitoring may be a solution for antepartum care during the COVID-19 pandemic. Remote FHR self-monitoring seemed to have a potential impact on improving antenatal care and expanding the monitoring capacity in settings where bulky wired or traditional equipment is unreliable.

Our findings identified that remote FHR self-monitoring was highly acceptable in nulliparous pregnant women. The hypothesis was that nulliparous pregnancies might lack experience and have a sense of “fear of the unknowns” emanating from the traditional fetal monitoring model.According to the study by Shakarami [20], nulliparous women was at higher risk of developing anxiety and stress compared to multiparous women. Hence, remote FHR monitoring, providing real-time fetal wellbeing, might reduce fear in nulliparous women. Remote FHR self-monitoring is a home-based telemedicine device that enhances the satisfaction of pregnant women. For outpatients, remote FHR self-monitoring led to more freedom and satisfaction, particularly for pregnant women at high risk. This remote system allowed pregnant women at high risk to monitor fetal wellbeing at home without frequent ambulatory visits or hospitalization. Previous clinical trials [21] have demonstrated that remote FHR monitoring successfully produced output data in 90% of instances for pregnant women at home after labor induction. Compared to multiparous pregnancies, more nulliparous pregnancies preferred remote FHR self-monitoring. Unsurprisingly, education level and economic level were factors that impacted the usage of remote FHR self-monitoring. Pregnant women opting for the traditional FHR monitoring model were more likely to be multiparous and not receiving government assistance. These findings emphasize the need for economic growth prior to the popularization of remote FHR self-monitoring to more populations in different health settings. A cross-sectional observational study enrolled 55 pregnant women and 7 obstetrics to use remote FHR self-monitoring and identified that wireless FHR monitoring displayed a favorable role in a low-resource setting [22]. Furthermore, Ryu and coworkers [20] performed a remote maternal and fetal monitoring system for both high- and low-resource settings and demonstrated that this remote system was usable and safe. However, only wireless maternal monitoring, not fetal monitoring, was provided for the low-resource setting (n = 485) in this trial [20]. The implementation of remote FHR self-monitoring in low-resource settings is still challenging.

A strength of this study is the clinical benefit of remote FHR self-monitoring in preventing or mitigating adverse fetal outcomes from the outpatient setting of a large, urban tertiary health center, which has not been previously published. Similar to the traditional FHR monitoring mode in the clinic, we found that remote FHR self-monitoring was similar and did not increase the risk of adverse neonatal outcomes, regardless of high-risk or low-risk pregnant women. Notably, there is no established strategy to prevent fetal distress. At present, we have not proven that remote FHR self-monitoring is helpful in preventing fetal distress. Further larger multicenter randomized trials are needed to clarify whether remote FHR monitoring can improve neonatal outcomes and reduce infant health care costs. In addition, we showed that the rate of cesarean section did not increase in pregnancies with remote FHR self-monitoring, which is encouraging feedback, as it could be complementary to traditional antenatal care. In addition, we assessed the potential factors affecting the use of remote FHR self-monitoring among pregnant women, which has not been a focus in previous research. We revealed that parity, education level, household income and health risk were associated with the usage of remote FHR self-monitoring.

The present study has several limitations, including the population being recruited from a single tertiary center, with a higher level of familiarity with smartphone technology in urban cities. Conyer [21] and colleagues reported that wireless remote fetal telemonitoring increased the adherence to antenatal care in rural areas. Further study will be needed to investigate whether the clinical impact of remote FHR self-monitoring would be similar in more rural populations. In addition, we did not assess the acceptability and satisfaction of pregnant women, which has been widely studied before [23, 24].

Conclusion

In summary, we highlight that remote fetal heart rate monitoring is a feasible, safe and effective assessment for antenatal care that does not increase the risk of cesarean section and adverse neonatal outcomes. Thus, remote FHR self-monitoring might overcome the limitations of traditional fetal monitoring models. When we expand the use of this technology across China, the education level and economic level of pregnant women should be considered. Additional larger, multicenter studies assessing the impact of remote FHR self-monitoring on obstetric outcomes in different health settings are needed.

Availability of data and materials

The datasets generated and/or analysed during the current study are not publicly available due patient privacy but are available from the corresponding author on reasonable request.

References

  1. Hanifiha M, et al. Global, regional, and national burden and quality of care index in children and adolescents: a systematic analysis for the global burden of disease study 1990–2017. PLoS One. 2022;17(4):e0267596.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Arabin B, et al. Prediction of fetal distress and poor outcome in prolonged pregnancy using Doppler ultrasound and fetal heart rate monitoring combined with stress tests (II). Fetal Diagn Ther. 1994;9(1):1–6.

    Article  CAS  PubMed  Google Scholar 

  3. Smith C, et al. Fetal acoustic stimulation testing. II. A randomized clinical comparison with the nonstress test. Am J Obstet Gynecol. 1986;155(1):131–4.

    Article  CAS  PubMed  Google Scholar 

  4. Reis-de-Carvalho C, Nogueira P, Ayres-de-Campos D. Quality of fetal heart rate monitoring with transabdominal fetal ECG during maternal movement in labor: a prospective study. Acta Obstet Gynecol Scand. 2022;101(11):1269–75.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Goldenberg R et al. COVID-19 antibody positivity over time and pregnancy outcomes in seven low-and-middle-income countries: a prospective, observational study of the global Network for women’s and children’s Health research. BJOG. 2023;130(4):366–76.

  6. Brahmbhatt D, Ross H, Moayedi Y. Digital technology application for improved responses to health care challenges: lessons learned from COVID-19. Can J Cardiol. 2022;38(2):279–91.

    Article  PubMed  Google Scholar 

  7. Houzé de l’Aulnoit A, et al. Development of a smart mobile data module for fetal monitoring in E-healthcare. J Med Syst. 2018;42(5):83.

    Article  PubMed  Google Scholar 

  8. Schwartz N, et al. Novel uterine contraction monitoring to enable remote, self-administered nonstress testing. Am J Obstet Gynecol. 2022;226(4):554.e1-554.e12.

    Article  PubMed  Google Scholar 

  9. Porter P, et al. Accuracy, clinical utility, and usability of a wireless self-guided fetal heart rate monitor. Obstet Gynecol. 2021;137(4):673–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Das M, et al. Clinical validation of mobile cardiotocograph device for intrapartum and antepartum monitoring compared to standard cardiotocograph: an inter-rater agreement study. J Family Reprod Health. 2019;13(2):109–15.

    PubMed  PubMed Central  Google Scholar 

  11. Zizzo A, et al. Home management by remote self-monitoring in intermediate- and high-risk pregnancies: a retrospective study of 400 consecutive women. Acta Obstet Gynecol Scand. 2022;101(1):135–44.

    Article  PubMed  Google Scholar 

  12. Butler Tobah Y, et al. Randomized comparison of a reduced-visit prenatal care model enhanced with remote monitoring. Am J Obstet Gynecol. 2019;221(6):638.e1-638.e8.

    Article  PubMed  Google Scholar 

  13. Kerner R, et al. Maternal self-administered fetal heart rate monitoring and transmission from home in high-risk pregnancies. Int J Gynaecol Obstet. 2004;84(1):33–9.

    Article  CAS  PubMed  Google Scholar 

  14. Tamaru S, et al. Feasibility of a mobile cardiotocogram device for fetal heart rate self-monitoring in low-risk singleton pregnant women. J Obstet Gynaecol Res. 2022;48(2):385–92.

    Article  PubMed  Google Scholar 

  15. Monincx W, et al. Maternal health, antenatal and at 8 weeks after delivery, in home versus in-hospital fetal monitoring in high-risk pregnancies. Eur J Obstet Gynecol Reprod Biol. 2001;94(2):197–204.

    Article  CAS  PubMed  Google Scholar 

  16. Nakagawa K, et al. Survey of attitudes of individuals who underwent remote prenatal check-ups and consultations in response to the COVID-19 pandemic. J Obstet Gynaecol Res. 2021;47(7):2380–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Fanelli A, et al. Prototype of a wearable system for remote fetal monitoring during pregnancy. Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:5815–8 IEEE Engineering in Medicine and Biology Society. Annual International Conference.

    PubMed  Google Scholar 

  18. Rauf Z, et al. Home labour induction with retrievable prostaglandin pessary and continuous telemetric trans-abdominal fetal ECG monitoring. PLoS One. 2011;6(11):e28129.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Mugyenyi G, et al. Functionality and acceptability of a wireless fetal heart rate monitoring device in term pregnant women in rural Southwestern Uganda. BMC Pregnancy Childbirth. 2017;17(1):178.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ryu D, et al. Comprehensive pregnancy monitoring with a network of wireless, soft, and flexible sensors in high- and low-resource health settings. Proc Natl Acad Sci. 2021;118(20):e2100466118.

    Article  Google Scholar 

  21. Tapia-Conyer R, et al. Improving perinatal care in the rural regions worldwide by wireless enabled antepartum fetal monitoring: a demonstration project. Int J Telemed Appl. 2015;2015:794180.

    PubMed  PubMed Central  Google Scholar 

  22. Porter P, et al. Accuracy, interpretability and usability study of a wireless self-guided fetal heartbeat monitor compared to cardiotocography. NPJ Digit Med. 2022;5(1):167.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Feng XL, et al. Factors affecting the frequency and contents of routine antenatal care in remote rural China in 2009–2016: an observational study. BJOG. 2022;129(7):1062–72.

    Article  PubMed  Google Scholar 

  24. Shakarami A, et al. Comparison of fear, anxiety and self-efficacy of childbirth among primiparous and multiparous women. BMC Pregnancy Childbirth. 2021;21(1):642.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

The statement on informed consent to participate

Written informed consent for participates of their clinical details was obtained.

Funding

This work was supported by Guangdong Provincial Natural Science Foundation (No. 2021A1515010411), China Medical Board Grant (No.21-413), Zhongshan Public welfare science and technology research Founadtion (No.2019B1012).

Author information

Authors and Affiliations

Authors

Contributions

Yanna Zhu and Yueqin Zhou analyzed and interpreted the patient data regarding the adrenal adenoma. Caixia Zhu was a major contributor in writing the manuscript. Fenge Cai, Jieying Wu and Qiang Wu collected the data of patients. Jingwan Huang recorded the follow-up of all patients. Yujie Gan and Haitian Chen guided this project. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Yanna Zhu or Haitian Chen.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Ethics Committee of the First Affiliated Hospital, Sun Yat-sen University. All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

NA.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gan, Y., Zhu, C., Zhou, Y. et al. Clinical efficacy and acceptability of remote fetal heart rate self-monitoring in Southern China. BMC Pregnancy Childbirth 23, 715 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12884-023-05985-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12884-023-05985-9

Keywords